The anti-cancer properties of the diterpenoid lactone Andrographolide have recently been recognized, and the biological effects of this naturally occurring product derived from Andrographis paniculata are likely related to reactive oxygen species signaling.
Introduction
Primary MCL, DLBCL and FL cells: Following written consent approved by the Northwestern University Institutional Review Board (IRB), peripheral blood was drawn from three patients with leukemic-phase FL, one with MCL, and two with transformed DLBCL. The 3 FL patients had bulky abdominal adenopathy (>12 cm) and a rapidly rising lymphocyte count (absolute lymphocyte count 238.5 K/μl) with FISH confirmation of t (14; 18) in 95% of nuclei.
The patient with MCL had newly diagnosed MCL with a WBC of 28,000/μl, with 96% malignant cells and had t (11; 14) by FISH in the blood and bone marrow. The 2 patients with DLBCL had transformed lymphoma with >100,000/μl circulating large cells. The peripheral blood was diluted 1:1 with PBS (Ca The AC 50 (defined herein as that concentration that achieved 50% apoptosis) was 40µM for Ramos at 72h, 40µM for Granta or HF-1 at 48h and 30µM for SUDHL4 at 48h.
To determine if apoptosis was related to ROS, we co-incubated cells with the anti-oxidant NAC.
In all cell lines, NAC completely abrogated andrographolide-induced apoptosis ( Figure 3A ) (p <0.05). These data suggest that apoptosis was related to the cellular redox state, perhaps as a consequence of depletion of the endogenous anti-oxidant GSH, since NAC restores intracellular
GSH.
Research. concentrations of between 1.9 and 3.8 μM can be achieved with doses of andrographolide commonly used in China (32) , and that 20 fold higher doses can be given safely (7). This is well within the range that resulted in biological effects and apoptosis in patient samples in our studies.
Further, based on our data ( Figure 5A ) andrographolide did not cause significant apoptosis in normal lymphocytes compared with patient samples or cell lines. Further, there was no hematologic toxicity seen in a Phase I trial in HIV and non-HIV patients (7).
The mechanism of ROS-dependent cell death related to andrographolide is not clear. Woo et al have reported that andrographolide up-regulates cellular-reduced glutathione in neonatal rat cardiomyocytes (NRCM) (33) . However, andrographolide has been found to react with reduced thiols (33), so that initially there is a reduction in GSH, which is then followed by activation of glutamine cysteine ligase (GCL) and its modifier subunit (GCLM) as an endogenous antioxidant cellular defensive response to GSH reduction. However, Ji et al have reported that andrographolide initially increased intracellular GSH levels which then decreased later, while inhibition of cellular GSH synthesis by BSO augmented andrographolide-induced cytotoxicity and apoptosis in Hep3B cells (34) . Our observation that NAC reverses andrographolide-induced It is interesting that we see both caspase 8 and 9 activation with andrographolide, suggesting that both intrinsic and extrinsic caspase pathways are involved in andrographolide-induced apoptosis in lymphoma. Zhou et al (37) have found that andrographolide may enhance TRAIL-induced apoptosis through death receptor 4 up-regulation, and that this is mediated through p53. Our data suggesting that the pan-caspase inhibitor was required to block andrographolide-induced apoptosis are consistent with a process that may involve both caspase pathways and/or other pathways. Currently, studies of death receptor pathways in andrographolide-induced apoptosis of lymphoma cells are ongoing.
It is also intriguing that our data with andrographolide are extant for cell lines from B-cell lymphomas with very different biological and molecular signatures and indeed, hold true for samples from patients with the corresponding clinical-pathological subtypes of lymphoma.
While there are marked differences in the clinical behavior of these three types of lymphoma that would argue against categorizing them as a single entity, it is possible that the activity of this natural diterpenoid lactone operates through biological pathways that are independent of the heretofore established biology of these lymphomas, and thereby will open new pathways to a common approach to treatment.
We have demonstrated that andrographolide, the active component of the plant Andrographis paniculata, causes cell death in lymphoma cell lines and in fresh malignant cells from lymphoma patients. The mechanism is related to the redox state of the cells, as it is blocked completely by 
